Amyotrophic lateral sclerosis: A 40-year personal perspective

Area of Science:

• Neurology
• Neuroscience
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a complex neurodegenerative disorder.
• Its etiology is multifactorial, involving polygenic influences and environmental factors, with familial cases accounting for less than 10%.

Purpose of the Study:

• To summarize the current understanding of ALS pathogenesis and therapeutic strategies.
• To highlight recent advancements in supportive care and emerging treatment modalities.

Main Methods:

• Review of existing literature on ALS genetics, pathophysiology, and clinical management.
• Analysis of recent therapeutic developments, including supportive care and novel treatment approaches.

Main Results:

• ALS onset precedes clinical symptoms by years; protein misfolding is a common pathological endpoint.
• Improved survival is linked to non-invasive ventilation (BiPAP) and percutaneous endoscopic gastrostomy (PEG) feeding.
• Symptomatic treatments have enhanced patient quality of life.

Conclusions:

• The complex nature of ALS has historically impeded therapeutic progress.
• Emerging therapies such as protective autoimmunity, vaccines, nanotechnology, and stem cell therapy show promise for future ALS treatment.
• Continued research into the multifactorial causes of ALS is crucial for developing effective interventions.